Zimmer (NYSE:ZMH) yesterday revealed the management team and post-merger business structure it expects to implement after the close of its pending $13.35 billion merger with crosstown rival Biomet, including its new name: Zimmer Biomet.
David Dvorak, now Zimmer’s president & CEO, will keep that role at Zimmer Biomet. Twelve other executives from both organizations will report to Dvorak, according to a press release. Sign up to get our free newsletters delivered straight to your inbox
“These announcements mark important milestones that will help advance the effective integration of our 2 companies upon closing,” Dvorak said in prepared remarks. “Zimmer and Biomet each have extraordinary talent across all levels, and we are confident that we have put in place a team and organizational structure to drive the combined company into this new chapter.
Help employers find you! Check out all the jobs and post your resume.
